Butterfly Network Inc

Butterfly Network Inc

BFLY · NYSE · Healthcare / Medical Devices

6.08USD-0.59 (-8.85%)

Price History

Full chart

Market Stats

Previous Close6.67
Open6.70
Day Range6.06 – 6.70
52-Week Range1.87 – 10.05
Volume4.29M
Market Cap2.51B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.29
Dividend Yield0.00%
Beta2.09
50-Day Avg8.05
200-Day Avg5.46

About

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Joseph M. DeVivo
  • Employees220
  • Headquarters1600 District Avenue, Burlington, MA, United States, 01803, USA
  • Websitehttps://www.butterflynetwork.com

Leadership

  • Mr. Joseph M. DeVivoCEO, President & Chairman of the Board · b. 1967
  • Dr. Jonathan M. Rothberg Ph.D.Founder & Director · b. 1964
  • Mr. John N. DohertyExecutive VP & CFO · b. 1965
  • Mr. Steven CashmanExecutive VP & Chief Business Officer · b. 1977
  • Ms. Megan CarlsonChief Accounting Officer & Senior VP of Finance & Accounting · b. 1983
  • Mr. Victor KuSenior VP & CTO · b. 1965
  • Ms. Kate DriscollVice President of Compliance, Quality & Regulatory
  • Mr. Nicholas CaezzaVP & Deputy General Counsel & Corporate Secretary · b. 1991
  • Ms. Mercedes KelemenVice President of Human Resources
  • Mr. John S. SotoSenior Vice President of International · b. 1964

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.53M27.58M46.25M62.56M73.39M65.90M82.06M97.61M
Growth (%)-+1707.54%+67.68%+35.27%+17.30%-10.21%+24.52%+18.96%
Cost of Revenue2.25M48.48M107.47M45.51M33.93M49.04M33.23M51.88M
Gross Profit-729.00K-20.89M-61.22M17.05M39.46M16.86M48.83M45.73M
Gross Margin-47.77%-75.75%-132.37%27.26%53.77%25.58%59.51%46.85%
Operating Expense52.36M81.40M100.40M209.78M232.48M162.47M123.24M132.15M
Operating Income-53.09M-102.30M-161.62M-192.73M-193.02M-145.61M-74.41M-86.42M
Operating Margin-3478.77%-370.87%-349.43%-308.04%-263.01%-220.96%-90.68%-88.53%
EBITDA-52.70M-98.94M-160.25M-29.55M-162.74M-123.04M-60.92M-67.38M
EBITDA Margin-3453.15%-358.70%-346.47%-47.23%-221.75%-186.71%-74.24%-69.03%
Net Income-50.77M-99.60M-162.75M-32.41M-168.72M-133.70M-72.49M-77.06M
Net Income Margin-3326.67%-361.10%-351.87%-51.80%-229.90%-202.88%-88.34%-78.95%
R&D34.95M48.93M49.74M74.46M88.04M55.62M37.80M36.26M
R&D as % of Total Revenue2290.56%177.41%107.54%119.01%119.97%84.39%46.07%37.15%
Interest Expense001.14M651.00K2.00K01.26M1.49M
Interest Expense % of Total Revenue0.00%0.00%2.47%1.04%0.00%0.00%1.54%1.53%

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets248.07M165.14M147.19M571.97M417.57M304.27M256.08M296.53M
Total Liabilities5.96M15.32M148.19M124.27M92.21M84.22M87.25M100.55M
Total Equity241.99M148.66M-994.00K447.69M325.36M220.05M168.83M195.98M
Cash214.58M90.00M60.21M422.84M162.56M134.64M88.78M150.49M
Total Debt--53.89M29.08M31.89M25.03M22.84M20.40M
Net Debt-214.58M-90.00M-6.31M-393.76M-130.67M-109.61M-65.94M-130.09M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-69.58M-120.43M-81.70M-189.19M-169.12M-98.82M-41.71M-12.70M
Investing Cash Flow-1.10M-4.47M-2.38M-9.87M-93.78M70.41M-2.66M-3.35M
Financing Cash Flow247.84M324.00K54.28M565.69M2.88M228.00K-1.50M77.76M
Capital Expenditure1.10M4.47M2.38M7.88M18.30M5.78M2.69M3.35M
Free Cash Flow-70.68M-124.90M-84.08M-197.06M-187.42M-104.60M-44.40M-16.05M
Dividends Paid--56.40M-----
FCF to OCF101.58%103.71%102.91%104.16%110.82%105.85%106.46%126.36%
Dividend Paid to FCF---67.09%-----

Earnings

Report DateDec 31, 2019Mar 31, 2020May 18, 2020Aug 14, 2020Nov 16, 2020Mar 29, 2021May 17, 2021Aug 9, 2021Nov 15, 2021Feb 28, 2022May 5, 2022Aug 3, 2022Nov 3, 2022Feb 28, 2023May 11, 2023Aug 3, 2023Nov 2, 2023Feb 28, 2024May 1, 2024Aug 1, 2024Nov 1, 2024Feb 26, 2025May 2, 2025Aug 1, 2025Oct 31, 2025Feb 26, 2026Apr 30, 2026Jul 30, 2026Oct 30, 2026
EPS Estimate0.000.000.000.00----0.24-0.25-0.26-0.25-0.27-0.24-0.22-0.19-0.16-0.15-0.13-0.12-0.10-0.09-0.08-0.07-0.05-0.05-0.06-0.05-0.05-0.05
EPS Actual-7.09-4.070.000.00-0.01-0.06-0.01-0.02-0.23-0.08-0.22-0.18-0.26-0.17-0.16-0.14-0.12-0.21-0.10-0.07-0.05-0.08-0.04-0.03-0.04-0.05-0.03-0.04-
Surprise-------91.67%8.00%69.23%12.00%33.33%-8.33%22.73%15.79%12.50%20.00%-61.54%16.67%30.00%44.44%0.00%42.86%40.00%20.00%16.67%40.00%20.00%-
Timing------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.51B
Enterprise Value2.34B
Trailing P/E0.00
Forward P/E0.00
Price / Sales22.34
Price / Book12.93
EPS-0.29
Book Value0.716
Revenue (TTM)112.14M
Gross Profit (TTM)76.44M
EBITDA-46.82M
Profit Margin-66.75%
Operating Margin-30.90%
Return on Equity-35.46%
Return on Assets-10.47%
Shares Outstanding244.86M
Shares Float219.93M
Beta2.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 10.50
  • Strong Buy
    4

Ownership Breakdown

Institutions
61.51%
Insiders
10.26%
Retail / Other
28.23%

Top Institutional Holders

  • BlackRock Inc
    15.96M5.99%
  • Glenview Capital Management LLC
    14.34M5.38%
  • Fosun International Ltd
    10.23M3.84%
  • Hood River Capital Management LLC
    8.62M3.24%
  • Vanguard Capital Management, LLC
    8.19M3.08%
  • D. E. Shaw & Co LP
    6.39M2.40%
  • State Street Corp
    5.54M2.08%
  • ARK Investment Management LLC
    5.23M1.96%
  • Geode Capital Management, LLC
    4.81M1.81%
  • Awm Investment Company Inc
    4.43M1.66%
  • Bank of America Corp
    4.17M1.56%
  • Nuveen, LLC
    3.75M1.41%
  • First Light Asset Management, LLC
    2.64M0.99%
  • SEI Investments Co
    2.30M0.86%

Top Fund Holders

  • Fidelity Growth Company Fund
    7.93M2.98%
  • Vanguard MStar Total Stk Mkt Idx Invest
    5.99M2.25%
  • iShares Russell 2000 ETF
    5.36M2.01%
  • ARK Genomic Revolution ETF
    5.05M1.90%
  • Hood River New Opportunities Inst
    4.27M1.60%
  • Fidelity Growth Company K6
    2.28M0.86%